Clinical Trials on Von Willebrand Disease, Type 3 in New Zealand
Total 10832 results
-
Baxalta now part of ShireCompletedVon Willebrand DiseaseUnited States, Germany, United Kingdom, Italy, Austria, Canada
-
Weill Medical College of Cornell UniversityWithdrawnVon Willebrand DiseaseUnited States
-
OctapharmaActive, not recruitingVon Willebrand DiseaseUnited States, Moldova, Republic of, Czechia, Germany, North Macedonia, Russian Federation, Ukraine
-
Baxalta now part of ShireCompletedVon Willebrand DiseaseUnited States, Spain, Australia, Taiwan, Czechia, Turkey, Ukraine, Netherlands, Italy, United Kingdom, Austria, Germany, Russian Federation
-
American Thrombosis and Hemostasis NetworkTakedaActive, not recruiting
-
BloodworksErgomed; Octapharma; Mary M. Gooley Hemophilia CenterRecruiting
-
Baylor College of MedicineShireActive, not recruiting
-
OctapharmaCompletedVon Willebrand DiseaseUnited States, Canada, Sweden, Spain, Uruguay, United Kingdom, Portugal, Argentina, Czechia, Germany
-
Baxalta now part of ShireCompletedVon Willebrand DiseaseNetherlands, Spain, United States, Belgium, Australia, United Kingdom, Austria, Italy, Bulgaria, Japan, Poland, Germany, India, Canada, Russian Federation, Sweden
-
Centers for Disease Control and PreventionCompletedBlood Coagulation Disorders | Blood Platelet Disorders | Menorrhagia | Hematologic Disease | Von Willebrand DiseaseUnited States
-
Arrowhead PharmaceuticalsCompletedNon-alcoholic SteatohepatitisNew Zealand
-
ABK BiomedicalCompletedMetastatic Colorectal Cancer | Liver Cancer | Hepatocellular Carcinoma Non-resectableNew Zealand
-
Malaghan Institute of Medical ResearchWellington Zhaotai Therapies Limited (WZTL)RecruitingMantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Lymphomas Non-Hodgkin's B-Cell | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL)New Zealand
-
Diatranz Otsuka LimitedCompleted
-
Margaret RagniNational Heart, Lung, and Blood Institute (NHLBI); Duke University; University...TerminatedVon Willebrand DiseasesUnited States
-
Insulet CorporationCompleted
-
North Shore Hospital, New ZealandCompletedObesity | Type 2 Diabetes MellitusNew Zealand
-
Edgar National Centre for Diabetes ResearchUniversity of OtagoUnknown
-
University of OtagoEdgar National Centre for Diabetes ResearchCompletedObesity | Type 2 Diabetes MellitusNew Zealand
-
Suzhou Alphamab Co., Ltd.Novotech (Australia) Pty LimitedCompleted
-
Christchurch Clinical Studies Trust LtdMedtronicUnknownType1diabetesNew Zealand
-
Tandem Diabetes Care, Inc.Recruiting
-
Provectus PharmaceuticalsCompleted
-
Auckland District Health BoardNovartis; University of Auckland, New Zealand; IGENZ, Ltd., AucklandUnknownClear Cell Renal Cell CarcinomaNew Zealand
-
Zhejiang Doer Biologics Co., Ltd.RecruitingHealthy, Obesity, MetabolicallyNew Zealand
-
Waikato HospitalWellington HospitalRecruitingGlioblastomaNew Zealand
-
National Cancer Institute (NCI)Celgene CorporationActive, not recruitingAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
Christchurch HospitalUnknownDiabetes Mellitus, Type 2New Zealand
-
Assembly BiosciencesNot yet recruitingRecurrent Genital Herpes Simplex Type 2New Zealand
-
National Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
University of Auckland, New ZealandNorth Shore Hospital, New Zealand; Waikato Hospital; Gut Cancer Foundation, New...Not yet recruitingIntraductal Papillary Mucinous Neoplasm of PancreasNew Zealand
-
National Cancer Institute (NCI)CompletedHIV Infection | Recurrent Grade 3 Follicular Lymphoma | Plasmablastic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Primary Effusion Lymphoma | AIDS-Related Primary Effusion Lymphoma | Ann Arbor Stage I Diffuse Large B-Cell Lymphoma | Ann Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor... and other conditionsUnited States
-
Mary M. Gooley Hemophilia CenterCompletedHemophilia | vonWillebrand Disease | Platelet Coagulation DisordersUnited States
-
MedImmune LLCCompleted
-
Samus Therapeutics, Inc.TerminatedRecurrent Glioblastoma Multiforme (GBM) | Grade 3 Isocitrate Dehydrogenase (IDH) Wildtype Astrocytoma | Grade 3 or 4 Astrocytoma | Glioblastoma SurgeryUnited States
-
Seagen Inc.TerminatedNon-Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma | DLBCL | Grade 3 Follicular LymphomaUnited States
-
Verve Therapeutics, Inc.Not yet recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Verve Therapeutics, Inc.Active, not recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Agenus Inc.Terminated
-
Memorial Sloan Kettering Cancer CenterAgios Pharmaceuticals, Inc.RecruitingChondrosarcoma | IDH1 Gene Mutation | Chondrosarcoma, Grade 2 | Chondrosarcoma, Grade 3United States
-
American Thrombosis and Hemostasis NetworkSanofi; Pfizer; Genentech, Inc.; CSL Behring; Hemophilia of Georgia, Inc.; Hemab TherapeuticsRecruitingHemophilia | Thrombosis | Thrombophilia | Sickle Cell Disease | Thalassemia | Bleeding Disorder | Von Willebrand Diseases | Factor IX Deficiency | Connective Tissue Disorder | Factor VIII Deficiency | Hematologic Disorder | Rare Bleeding Disorder | Platelet DisorderUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell LymphomaUnited States
-
University of Auckland, New ZealandLeukaemia & Blood Cancer New ZealandActive, not recruiting
-
Teachers College, Columbia UniversityActive, not recruitingSpinocerebellar Ataxia Type 3 | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6 | Spinocerebellar Ataxia Type 7United States
-
Bispebjerg HospitalCompleted
-
Peter MacCallum Cancer Centre, AustraliaActive, not recruitingHodgkin LymphomaAustralia, New Zealand
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyEnrolling by invitationKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
-
Smith & Nephew, Inc.RecruitingAvascular Necrosis | Non-inflammatory Degenerative Joint Disease, Including Osteoarthritis | Requires Correction of Functional Deformity | Requires Treatment of Fractures That Were Unmanageable Using Other TechniquesNew Zealand, Australia, Hong Kong
-
Antisoma ResearchCompletedMetastatic Renal Cell Carcinoma | Metastatic Malignant MelanomaUnited Kingdom, New Zealand
-
MedImmune LLCCompletedHealthyUnited States, Australia, Spain, Germany, Canada, Finland, South Africa, Brazil, Israel